534 related articles for article (PubMed ID: 18414108)
21. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
[TBL] [Abstract][Full Text] [Related]
22. A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
Topouzis F; Melamed S; Danesh-Meyer H; Wells AP; Kozobolis V; Wieland H; Andrew R; Wells D
Eur J Ophthalmol; 2007; 17(2):183-90. PubMed ID: 17415690
[TBL] [Abstract][Full Text] [Related]
23. Effects of travoprost 0.004% ophthalmic solution, six weeks after its laminated packaging had been removed, in primary open-angle glaucoma: a randomized, controlled, investigator-blinded study.
Reis R; dos Santos LC; Vila MP; Magacho L
Clin Ther; 2004 Dec; 26(12):2121-7. PubMed ID: 15823775
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the efficacy and safety of travoprost with a fixed-combination of dorzolamide and timolol in patients with open-angle glaucoma or ocular hypertension.
Suzuki ER; Franklin LM; da Silva LJ; Figueiredo CR; Netto JA; Batista WD
Curr Med Res Opin; 2006 Sep; 22(9):1799-805. PubMed ID: 16968583
[TBL] [Abstract][Full Text] [Related]
25. Inter-visit intraocular pressure range: an alternative parameter for assessing intraocular pressure control in clinical trials.
Varma R; Hwang LJ; Grunden JW; Bean GW
Am J Ophthalmol; 2008 Feb; 145(2):336-42. PubMed ID: 18222194
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the role of travoprost 0.004% ophthalmic solution in the management of open angle glaucoma and ocular hypertensive patients.
Chiselită D;
Oftalmologia; 2007; 51(2):81-6. PubMed ID: 17937041
[TBL] [Abstract][Full Text] [Related]
27. Travoprost 0.004%/timolol 0.5%-fixed combination with and without benzalkonium chloride: a prospective, randomized, doubled-masked comparison of safety and efficacy.
Kitazawa Y; Smith P; Sasaki N; Kotake S; Bae K; Iwamoto Y
Eye (Lond); 2011 Sep; 25(9):1161-9. PubMed ID: 21701528
[TBL] [Abstract][Full Text] [Related]
28. Intraocular pressure control over 24 hours using travoprost and timolol fixed combination administered in the morning or evening in primary open-angle and exfoliative glaucoma.
Konstas AG; Tsironi S; Vakalis AN; Nasr MB; Stewart JA; Nelson LA; Stewart WC
Acta Ophthalmol; 2009 Feb; 87(1):71-6. PubMed ID: 19178390
[TBL] [Abstract][Full Text] [Related]
29. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
Bournias TE; Lai J
Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
[TBL] [Abstract][Full Text] [Related]
30. Effect of benzalkonium chloride-free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study.
Lopes JF; Hubatsch DA; Amaris P
BMC Ophthalmol; 2015 Nov; 15():166. PubMed ID: 26563363
[TBL] [Abstract][Full Text] [Related]
31. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
Hatanaka M; Grigera DE; Barbosa WL; Jordao M; Susanna R
J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
[TBL] [Abstract][Full Text] [Related]
32. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
Trinquand C; Romanet JP; Nordmann JP; Allaire C;
J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
[TBL] [Abstract][Full Text] [Related]
33. Intraocular pressure-lowering efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension.
Cantor LB; Hoop J; Morgan L; Wudunn D; Catoira Y;
Br J Ophthalmol; 2006 Nov; 90(11):1370-3. PubMed ID: 16825272
[TBL] [Abstract][Full Text] [Related]
34. Twenty-four-hour intraocular pressure control with the travoprost/timolol maleate fixed combination compared with travoprost when both are dosed in the evening in primary open-angle glaucoma.
Konstas AG; Mikropoulos D; Haidich AB; Ntampos KS; Stewart WC
Br J Ophthalmol; 2009 Apr; 93(4):481-5. PubMed ID: 19019932
[TBL] [Abstract][Full Text] [Related]
35. A comparison of morning and evening instillation of a combination travoprost 0.004%/timolol 0.5% ophthalmic solution.
Denis P; Andrew R; Wells D; Friren B
Eur J Ophthalmol; 2006; 16(3):407-15. PubMed ID: 16761242
[TBL] [Abstract][Full Text] [Related]
36. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears.
Kahook MY; Noecker RJ
Cornea; 2008 Apr; 27(3):339-43. PubMed ID: 18362664
[TBL] [Abstract][Full Text] [Related]
37. Sustained effect of travoprost on diurnal and nocturnal intraocular pressure.
Sit AJ; Weinreb RN; Crowston JG; Kripke DF; Liu JH
Am J Ophthalmol; 2006 Jun; 141(6):1131-3. PubMed ID: 16765686
[TBL] [Abstract][Full Text] [Related]
38. Twelve-month, randomized, controlled trial of bimatoprost 0.01%, 0.0125%, and 0.03% in patients with glaucoma or ocular hypertension.
Katz LJ; Cohen JS; Batoosingh AL; Felix C; Shu V; Schiffman RM
Am J Ophthalmol; 2010 Apr; 149(4):661-671.e1. PubMed ID: 20346780
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of latanoprost versus travoprost in exfoliative glaucoma patients.
Konstas AG; Kozobolis VP; Katsimpris IE; Boboridis K; Koukoula S; Jenkins JN; Stewart WC
Ophthalmology; 2007 Apr; 114(4):653-7. PubMed ID: 17197028
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trials.
Aptel F; Cucherat M; Denis P
J Glaucoma; 2008 Dec; 17(8):667-73. PubMed ID: 19092464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
